Analysis Metabolite Name Measured Value Units Gender Glycemic status Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-11609Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-11664Peak area normalizedfemale normoglycemic no neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-12379Peak area normalizedmale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-12547Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-12661Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-13176Peak area normalizedfemale normoglycemic Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-13634Peak area normalizedmale pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-13890Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-16694Peak area normalizedmale pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-17421Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-18145Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-27307Peak area normalizedmale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-28889Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEAZELAIC ACID (M-H)-335392Peak area normalizedfemale diabetic no neuropathy

Return to search page
  logo